Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0XN8A
|
||||
| Former ID |
DNC014221
|
||||
| Drug Name |
INFRACTOPICRIN
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530743] | ||
| Formula |
C17H13ClN2O
|
||||
| Canonical SMILES |
C1CC2=CC(=O)N3C4=CC=CC=C4C5=C3C2=[N+](C1)C=C5.[Cl-]
|
||||
| InChI |
1S/C17H13N2O.ClH/c20-15-10-11-4-3-8-18-9-7-13-12-5-1-2-6-14(12)19(15)17(13)16(11)18;/h1-2,5-7,9-10H,3-4,8H2;1H/q+1;/p-1
|
||||
| InChIKey |
ANXYOVQDHIBQTM-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [530743] | |
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||